Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04278196
Other study ID # 2020SDU-QILU-24
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date November 30, 2020

Study information

Verified date May 2021
Source Shandong University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

During the past several years,MCE(magnet controlled endoscopy)has made great process in detecting lesions of gastric as well as screening. Compared with conventional endoscopy, magnetically controlled capsule endoscopy can be further optimized in gastric examination. So we make an AI for operators to help improve the quality of MCE and record the mucosa visibilty of gastirc.


Description:

We developed a new artificial intelligence for quality improving during the operation of magnet controlled endoscopy. The AI can help operators screen every part of gastric and then evaluate the visibilty of gastic. Also, It can be record time of the opration. Other than that ,we compared the performancce of AI with experts.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date November 30, 2020
Est. primary completion date October 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - patients between 18 and75 - patients who can sign informed consent Exclusion Criteria: - patients who are unsuitable to accept the check

Study Design


Related Conditions & MeSH terms

  • Magnet Controlled Capsule Endoscopy

Intervention

Other:
AI-Box
AI-box is a system fixed adjacent to magnet controlled capsule endoscopy. Patients who accept the check of magnet controlled capsule endoscopywill be enrolled .

Locations

Country Name City State
China Department of Gastroenterology, Qilu Hospital, Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The integrity of the magnet controlled capsule endoscopy The performance of the operator developing the MCE in screen the gastric without omissions 2 months
Primary The visibilty of the gastric Evaluating the performance of AI to recognize the visibility of gastric mucosa 2 months
Primary The time of operation in gastric Calculating the time of the magnet controlled capsule endoscapy 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT04954677 - A Real-time Quality Control System of Magnetic-controlled Capsule Gastroscopy N/A